TIAA CREF Investment Management LLC cut its stake in Medidata Solutions Inc (NASDAQ:MDSO) by 7.5% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 125,792 shares of the company’s stock after selling 10,241 shares during the period. TIAA CREF Investment Management LLC owned about 0.21% of Medidata Solutions worth $9,222,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in MDSO. Teachers Advisors LLC raised its holdings in shares of Medidata Solutions by 3.3% in the third quarter. Teachers Advisors LLC now owns 126,817 shares of the company’s stock valued at $9,297,000 after buying an additional 4,109 shares during the last quarter. Disciplined Growth Investors Inc. MN raised its holdings in shares of Medidata Solutions by 1.9% in the third quarter. Disciplined Growth Investors Inc. MN now owns 943,458 shares of the company’s stock valued at $69,165,000 after buying an additional 17,304 shares during the last quarter. Ashford Capital Management Inc. raised its holdings in shares of Medidata Solutions by 5.1% in the third quarter. Ashford Capital Management Inc. now owns 224,886 shares of the company’s stock valued at $16,486,000 after buying an additional 10,875 shares during the last quarter. Macquarie Group Ltd. raised its holdings in shares of Medidata Solutions by 7.0% in the third quarter. Macquarie Group Ltd. now owns 24,834 shares of the company’s stock valued at $1,821,000 after buying an additional 1,616 shares during the last quarter. Finally, Thrivent Financial for Lutherans raised its holdings in shares of Medidata Solutions by 5.8% in the third quarter. Thrivent Financial for Lutherans now owns 14,280 shares of the company’s stock valued at $1,047,000 after buying an additional 787 shares during the last quarter.

Shares of Medidata Solutions stock opened at $67.18 on Monday. Medidata Solutions Inc has a 52-week low of $59.60 and a 52-week high of $88.87. The company has a current ratio of 2.52, a quick ratio of 2.52 and a debt-to-equity ratio of 0.15. The stock has a market cap of $4.13 billion, a PE ratio of 79.04, a PEG ratio of 4.00 and a beta of 1.32.

Medidata Solutions (NASDAQ:MDSO) last issued its quarterly earnings results on Thursday, October 18th. The company reported $0.42 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.36 by $0.06. Medidata Solutions had a net margin of 8.43% and a return on equity of 10.70%. The business had revenue of $163.41 million for the quarter, compared to analyst estimates of $162.09 million. During the same period in the previous year, the business posted $0.33 earnings per share. The business’s revenue was up 17.6% compared to the same quarter last year. Equities analysts anticipate that Medidata Solutions Inc will post 0.85 earnings per share for the current fiscal year.

In other Medidata Solutions news, Director Robert Taylor sold 2,120 shares of the company’s stock in a transaction dated Monday, January 7th. The shares were sold at an average price of $64.70, for a total transaction of $137,164.00. Following the transaction, the director now directly owns 41,916 shares in the company, valued at $2,711,965.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Rouven Bergmann sold 10,000 shares of the company’s stock in a transaction dated Wednesday, November 28th. The stock was sold at an average price of $75.00, for a total transaction of $750,000.00. Following the transaction, the chief financial officer now owns 88,862 shares in the company, valued at $6,664,650. The disclosure for this sale can be found here. Insiders have sold 36,150 shares of company stock worth $2,676,186 over the last 90 days. 4.70% of the stock is currently owned by company insiders.

MDSO has been the subject of a number of research reports. BidaskClub cut shares of Medidata Solutions from a “buy” rating to a “hold” rating in a report on Monday, January 7th. Piper Jaffray Companies reduced their target price on shares of Medidata Solutions from $96.00 to $93.00 in a report on Thursday, October 18th. Zacks Investment Research cut shares of Medidata Solutions from a “hold” rating to a “sell” rating in a report on Wednesday, December 19th. ValuEngine cut shares of Medidata Solutions from a “buy” rating to a “hold” rating in a report on Monday, September 17th. Finally, TheStreet lowered shares of Medidata Solutions from a “b” rating to a “c+” rating in a research note on Thursday, December 20th. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and six have given a buy rating to the company. Medidata Solutions currently has an average rating of “Hold” and a consensus price target of $82.82.

COPYRIGHT VIOLATION NOTICE: This report was published by Watch List News and is the sole property of of Watch List News. If you are accessing this report on another domain, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The correct version of this report can be accessed at https://www.watchlistnews.com/tiaa-cref-investment-management-llc-trims-position-in-medidata-solutions-inc-mdso/2744878.html.

About Medidata Solutions

Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development of new therapies. The company's platform solutions include data capture and management and trial planning and management.

Recommended Story: Why does a company issue an IPO?

Institutional Ownership by Quarter for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.